RadNet (RDNT) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
18 May, 2026Executive summary
Achieved record first quarter revenue of $575.6 million, up 22.1% year-over-year, and adjusted EBITDA of $63.3 million, up 36.3%, despite $13M revenue and $9M EBITDA impact from severe winter weather.
Digital Health segment revenue surged 51.5% to $29.1 million, with ARR nearly doubling to $96.9 million, reflecting strong AI and informatics growth and recent acquisitions.
Imaging Center segment expanded to 435 centers, with same-center revenue up 8.9% and advanced imaging volumes now representing 29.3% of procedural volume.
Net loss attributable to common stockholders narrowed to $33.5 million, with adjusted diluted loss per share improving to $(0.28) from $(0.34) year-over-year.
Completed significant acquisitions in Florida, Indiana, and France, and expanded Digital Health with the Gleamer SAS acquisition.
Financial highlights
Imaging Center revenue reached $556.8 million (up 20.7% year-over-year); Digital Health revenue was $29.1 million (up 51.5%).
Adjusted EBITDA margin for Imaging Center segment improved by 52 basis points after weather adjustments.
Cash and equivalents at quarter-end were $455.3 million; leverage ratio (Net Debt/Adjusted EBITDA) slightly below 2.0.
Days sales outstanding (DSO) reached a record low of 29.5 days.
Cash flow from operations was $79.0 million; net cash used in investing activities was $370.97 million, mainly for acquisitions.
Outlook and guidance
2026 Imaging Center guidance raised: revenue now $2,355–$2,405 million, adjusted EBITDA $340–$353 million, free cash flow $112–$122 million.
Digital Health full-year guidance reaffirmed: $135M–$145M revenue, $10M–$12M adjusted EBITDA before non-capitalized R&D.
Over 70% of studies expected to run through clinical AI by year-end; all radiologist reports to use AI-powered summarization.
Sufficient liquidity and borrowing capacity to fund operations and future acquisitions.
Expect continued margin improvement in Digital Health as recent investments and acquisitions are integrated.
Latest events from RadNet
- Record revenue, major AI acquisition, and strong 2026 growth outlook highlight the quarter.RDNT
Q4 20253 May 2026 - Annual meeting covers director elections, auditor ratification, compensation, and equity plan expansion.RDNT
Proxy filing20 Apr 2026 - Key votes on directors, auditor, executive pay, and equity plan set for June 2026 meeting.RDNT
Proxy filing20 Apr 2026 - AI-powered radiology and digital health drive double-digit growth and industry transformation.RDNT
44th Annual J.P. Morgan Healthcare Conference16 Apr 2026 - Advanced imaging, digital health, and AI drive robust growth and industry leadership into 2026.RDNT
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - Strong growth, digital health expansion, and AI integration drive positive 2026 outlook.RDNT
Barclays 28th Annual Global Healthcare Conference12 Mar 2026 - Acquisition forms global radiology AI leader, targeting $140M ARR and rapid integration by 2026.RDNT
M&A announcement5 Mar 2026 - Advanced imaging, AI, and acquisitions drive robust growth and margin expansion for 2026.RDNT
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Acquisition of Gleamer accelerates DeepHealth's leadership in radiology AI and automation.RDNT
Investor update2 Mar 2026